Oncology and Hematology - Global Oncology Academy

161-176 of 790

Emerging Therapeutic Strategies in Metastatic NSCLC
Emerging Therapeutic Strategies in Metastatic NSCLC
Project Oncology®
Emerging Therapeutic Strategies in Metastatic NSCLC
Brian P. McDonough, MD, FAAFP; Urs Weber, MD
- Brian P. McDonough, MD, FAAFP
- Urs Weber, MD
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Project Oncology®
Interpreting Perioperative Trial Designs in Resectable NSCLC Research
Charles Turck, PharmD, BCPS, BCCCP; Laura Alder, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Laura Alder, MD
- Christine Bestvina, MD
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
COVID-19: On The Frontlines
Turning Cold Tumors Hot with mRNA COVID-19 Vaccines
Hallie Blevins, PhD; Marlene Mimi Maeusli, PhD.
- Hallie Blevins, PhD
- Marlene Mimi Maeusli, PhD.
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Project Oncology®
Navigating AKT Inhibitor-Associated Adverse Events in HR+/HER2- Advanced Breast Cancer
Alexandria May, PharmD, BCPS; Adam Brufsky, MD, PhD
- Alexandria May, PharmD, BCPS
- Adam Brufsky, MD, PhD
Addressing Barriers to CAR T Referral in R/R LBCL
Addressing Barriers to CAR T Referral in R/R LBCL
Project Oncology®
Addressing Barriers to CAR T Referral in R/R LBCL
Steve Jackson, PharmD; Matthew J. Matasar, MD
- Steve Jackson, PharmD
- Matthew J. Matasar, MD
- Tycel Phillips, MD
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Project Oncology®
Coordinating Care for mCSPC Patients Receiving Androgen Receptor Pathway Inhibitors
Charles Turck, PharmD, BCPS, BCCCP; Daniel Geynisman, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Daniel Geynisman, MD
- Jonathan Henderson, MD
Optimizing Multidisciplinary Care in Perioperative NSCLC
Optimizing Multidisciplinary Care in Perioperative NSCLC
Project Oncology®
Optimizing Multidisciplinary Care in Perioperative NSCLC
Steve Jackson, PharmD; David Tom Cooke, MD, FACS
- Steve Jackson, PharmD
- David Tom Cooke, MD, FACS
- Joshua Reuss, MD
Blood-Based Colorectal Cancer Screening: Where Do We Stand?
Blood-Based Colorectal Cancer Screening: Where Do We Stand?
Clinician's Roundtable
Blood-Based Colorectal Cancer Screening: Where Do We Stand?
Peter Buch, MD, FACG, AGAF, FACP; Aasma Shaukat, MD, MPH
- Peter Buch, MD, FACG, AGAF, FACP
- Aasma Shaukat, MD, MPH
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Project Oncology®
Choosing Between Neoadjuvant and Perioperative Strategies in NSCLC
Steve Jackson, PharmD; Raghava Reddy Induru, MD
- Steve Jackson, PharmD
- Raghava Reddy Induru, MD
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Project Oncology®
Managing AKT Inhibitor-Associated AEs in HR+/HER2- Advanced Breast Cancer
Charles Turck, PharmD, BCPS, BCCCP; Neil M. Iyengar, MD
- Charles Turck, PharmD, BCPS, BCCCP
- Neil M. Iyengar, MD
- Sarah H. Donahue, MPH, NP
Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Project Oncology®
Choosing the Right ARPI in Metastatic Castration-Sensitive Prostate Cancer
Brian P. McDonough, MD, FAAFP; Bilal Siddiqui, MD
- Brian P. McDonough, MD, FAAFP
- Bilal Siddiqui, MD
Improving CRC Screening Workflows: A PCP's Recommendations
Improving CRC Screening Workflows: A PCP's Recommendations
Clinician's Roundtable
Improving CRC Screening Workflows: A PCP's Recommendations
Natalia Usoltseva MD, FACP, MHA
- Natalia Usoltseva MD, FACP, MHA
Improving CRC Screening Conversations in Primary Care
Improving CRC Screening Conversations in Primary Care
Clinician's Roundtable
Improving CRC Screening Conversations in Primary Care
Natalia Usoltseva MD, FACP, MHA
- Natalia Usoltseva MD, FACP, MHA
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
CME/CE
Improving Quality Care Across the Spectrum of HER2 Expression in HR+ Metastatic Breast Cancers: Practice Changes to Improve Care
Joseph Kim, MD, MPH, MBA, FACHE; Samir Dalia, MD
0.25 credits
- Joseph Kim, MD, MPH, MBA, FACHE
- Samir Dalia, MD
- Christopher Jurief
0.25 credits
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Project Oncology®
Urinary and Circulating Tumor DNA in Muscle-Invasive Bladder Cancer: NIAGARA Data
Charles Turck, PharmD, BCPS, BCCCP; Petros Grivas, MD, PhD
- Charles Turck, PharmD, BCPS, BCCCP
- Petros Grivas, MD, PhD
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
CME/CE
Redefining Immunotherapy Access: Integrating Subcutaneous Checkpoint Inhibitors Across Solid Tumors
Dr. Felip; Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits
- Dr. Felip
- Kristi Orbaugh, MSN, RNP, AOCN
0.25 credits

Previous
1
2
…
9
10
11
12
13
…
49
50
Next

11/11